NASDAQ:ITMR Itamar Medical Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Itamar Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $21.18 -0.45 (-2.08 %) (As of 09/24/2020 12:00 AM ET) Add Compare Share Today's Range$20.47Now: $21.18▼$21.2850-Day Range$19.05MA: $22.11▼$25.9652-Week Range$7.66Now: $21.18▼$29.00Volume10,522 shsAverage Volume30,649 shsMarket Capitalization$236.71 millionP/E RatioN/ADividend YieldN/ABeta1.53 ProfileAnalyst RatingsChartCompetitorsEarningsInstitutional OwnershipHeadlinesShort InterestSocial Media Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingItamar Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $26.55, Itamar Medical has a forecasted upside of 25.4% from its current price of $21.18.Amount of Analyst CoverageItamar Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesItamar Medical has received 32 “outperform” votes. (Add your “outperform” vote.)Underperform VotesItamar Medical has received 31 “underperform” votes. (Add your “underperform” vote.)Community SentimentItamar Medical has received 50.79% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Itamar Medical and other stocks. Vote “Outperform” if you believe ITMR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ITMR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldItamar Medical does not currently pay a dividend.Dividend GrowthItamar Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Itamar Medical insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 30.59% of the stock of Itamar Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Itamar Medical are expected to grow in the coming year, from ($0.70) to ($0.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Itamar Medical is -37.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Itamar Medical is -37.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.33 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ITMR Previous Symbol CUSIPN/A CIKN/A WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$31.26 million Price / Sales7.57 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees184 Outstanding Shares11,176,000Market Cap$236.71 million Next Earnings Date11/24/2020 (Estimated) OptionableNot Optionable $21.18 -0.45 (-2.08 %) (As of 09/24/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ITMR News and Ratings via Email Sign-up to receive the latest news and ratings for ITMR and its competitors with MarketBeat's FREE daily newsletter. Itamar Medical (NASDAQ:ITMR) Frequently Asked Questions How has Itamar Medical's stock been impacted by COVID-19 (Coronavirus)? Itamar Medical's stock was trading at $11.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ITMR shares have increased by 90.6% and is now trading at $21.18. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Itamar Medical? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Itamar Medical in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Itamar Medical. When is Itamar Medical's next earnings date? Itamar Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 24th 2020. View our earnings forecast for Itamar Medical. How were Itamar Medical's earnings last quarter? Itamar Medical Ltd. (NASDAQ:ITMR) posted its earnings results on Tuesday, August, 11th. The company reported ($0.22) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.21) by $0.01. The business had revenue of $8.89 million for the quarter, compared to the consensus estimate of $7.92 million. View Itamar Medical's earnings history. What price target have analysts set for ITMR? 5 Wall Street analysts have issued 1 year price targets for Itamar Medical's shares. Their forecasts range from $22.00 to $30.00. On average, they expect Itamar Medical's stock price to reach $26.55 in the next twelve months. This suggests a possible upside of 25.4% from the stock's current price. View analysts' price targets for Itamar Medical. Are investors shorting Itamar Medical? Itamar Medical saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 422,200 shares, an increase of 43.8% from the August 15th total of 293,600 shares. Based on an average daily trading volume, of 26,400 shares, the short-interest ratio is currently 16.0 days. View Itamar Medical's Short Interest. Who are some of Itamar Medical's key competitors? Some companies that are related to Itamar Medical include I-Mab (ARQT), Surgery Partners (SGRY), Translate Bio (TBIO), Arvinas (ARVN), BioXcel Therapeutics (BTAI), Atara Biotherapeutics (ATRA), GenMark Diagnostics (GNMK), National HealthCare (NHC), National HealthCare (NHC), Retrophin (RTRX), Heska (HSKA), Arcturus Therapeutics (ARCT), Myriad Genetics (MYGN), Quanterix (QTRX) and Vectura Group (VEGPF). View all competitors. What other stocks do shareholders of Itamar Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Itamar Medical investors own include Gilead Sciences (GILD), AbbVie (ABBV), Carnival (CCL), Energy Transfer LP Unit (ET), KeyCorp (KEY), Occidental Petroleum (OXY), Pfizer (PFE), Primo Water (PRMW), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT). Who are Itamar Medical's key executives? Itamar Medical's management team includes the following people: Mr. Gilad Glick, Pres, CEO and Acting VP of Marketing & Sales (Age 47, Pay $561k)Mr. Shy Basson, CFO & COO of U.S. (Age 48, Pay $397k)Mr. Itay Kariv, VP of R&D and Technology (Age 61, Pay $243k)Mr. Eilon Livne, VP of Sales & Channels Devel. EMEA (Age 49, Pay $209k)Prof. Peretz Lavie, Founder What is Itamar Medical's stock symbol? Itamar Medical trades on the NASDAQ under the ticker symbol "ITMR." Who are Itamar Medical's major shareholders? Itamar Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (1.41%), Russell Investments Group Ltd. (1.37%), Roubaix Capital LLC (0.26%), Schonfeld Strategic Advisors LLC (0.19%) and Jane Street Group LLC (0.16%). Which institutional investors are selling Itamar Medical stock? ITMR stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC. Which institutional investors are buying Itamar Medical stock? ITMR stock was purchased by a variety of institutional investors in the last quarter, including Roubaix Capital LLC, Schonfeld Strategic Advisors LLC, Russell Investments Group Ltd., and Jane Street Group LLC. How do I buy shares of Itamar Medical? Shares of ITMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Itamar Medical's stock price today? One share of ITMR stock can currently be purchased for approximately $21.18. How big of a company is Itamar Medical? Itamar Medical has a market capitalization of $236.71 million and generates $31.26 million in revenue each year. Itamar Medical employs 184 workers across the globe. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
